Genentech Adds Black Box Warning to Xolair

Drug Industry Daily
A A
Genentech has updated the labeling for its asthma drug Xolair, adding a black box warning to alert patients of the risk of anaphylaxis, the FDA announced.

To View This Article:

Login

Subscribe To Drug Industry Daily